Sigachi Industries Limited (SIGACHI.BO)
INR 37.71
(4.63%)
INR 37.71
(4.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 571.8 Million INR | 31.54% |
| 2022 | 435.36 Million INR | 8.74% |
| 2021 | 400.37 Million INR | 32.31% |
| 2020 | 302.6 Million INR | 48.95% |
| 2019 | 203.15 Million INR | 6.85% |
| 2018 | 190.12 Million INR | 174.65% |
| 2017 | 69.22 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 131.6 Million INR | -13.0% |
| 2023 Q3 | 161.14 Million INR | 6.37% |
| 2023 Q2 | 151.49 Million INR | 39.3% |
| 2023 Q4 | 151.27 Million INR | -6.13% |
| 2023 Q1 | 108.75 Million INR | 48.66% |
| 2023 FY | 572.67 Million INR | 31.54% |
| 2022 Q4 | 73.15 Million INR | -25.54% |
| 2022 Q3 | 98.24 Million INR | -27.65% |
| 2022 Q2 | 135.79 Million INR | 5.96% |
| 2022 Q1 | 128.15 Million INR | 10.14% |
| 2022 FY | 435.36 Million INR | 8.74% |
| 2021 Q2 | 98.63 Million INR | 9.72% |
| 2021 FY | 400.37 Million INR | 32.31% |
| 2021 Q4 | 116.36 Million INR | 21.87% |
| 2021 Q3 | 95.48 Million INR | -3.19% |
| 2021 Q1 | 89.89 Million INR | -1.75% |
| 2020 FY | 302.6 Million INR | 48.95% |
| 2020 Q3 | 71.13 Million INR | -10.38% |
| 2020 Q2 | 79.37 Million INR | 31.0% |
| 2020 Q1 | 60.59 Million INR | 0.0% |
| 2020 Q4 | 91.49 Million INR | 28.62% |
| 2019 FY | 203.15 Million INR | 6.85% |
| 2018 FY | 190.12 Million INR | 174.65% |
| 2017 FY | 69.22 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 90.715% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 98.198% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 87.857% |
| Granules India Limited | 4.05 Billion INR | 85.892% |
| Indoco Remedies Limited | 984.6 Million INR | 41.926% |
| Achyut Healthcare Limited | 5.73 Million INR | -9875.611% |
| Ajanta Pharma Limited | 8.16 Billion INR | 92.994% |
| Alkem Laboratories Limited | 17.95 Billion INR | 96.816% |
| Alpa Laboratories Limited | 167.76 Million INR | -240.835% |
| Brooks Laboratories Limited | -195.91 Million INR | 391.856% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 64.596% |
| Bajaj HealthCare Limited | -837.93 Million INR | 168.24% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 24.219% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 98.973% |
| Eris Lifesciences Limited | 3.91 Billion INR | 85.413% |
| FDC Limited | 3.05 Billion INR | 81.266% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 103.808% |
| Gufic Biosciences Limited | 861.35 Million INR | 33.616% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 86.417% |
| Ipca Laboratories Limited | 5.47 Billion INR | 89.553% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -154.553% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 389.837% |
| Lasa Supergenerics Limited | -217.3 Million INR | 363.132% |
| Laurus Labs Limited | 1.6 Billion INR | 64.385% |
| Lupin Limited | 19.14 Billion INR | 97.013% |
| Mankind Pharma Limited | 19.12 Billion INR | 97.011% |
| Medicamen Biotech Limited | 109.31 Million INR | -423.101% |
| Medico Remedies Limited | 82.9 Million INR | -589.674% |
| Megasoft Limited | -127.46 Million INR | 548.592% |
| NATCO Pharma Limited | 13.88 Billion INR | 95.881% |
| Piramal Pharma Limited | 178.2 Million INR | -220.877% |
| RPG Life Sciences Limited | 876.6 Million INR | 34.77% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.403% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 80.958% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -125.882% |
| Unichem Laboratories Limited | -704.74 Million INR | 181.136% |
| Wanbury Limited | 559.56 Million INR | -2.187% |
| Windlas Biotech Limited | 581.87 Million INR | 1.73% |
| ZIM Laboratories Limited | 172.46 Million INR | -231.549% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 98.518% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 114.767% |
| Divi's Laboratories Limited | 16 Billion INR | 96.426% |
| Hester Biosciences Limited | 188.89 Million INR | -202.717% |
| Procter & Gamble Health Limited | 2 Billion INR | 71.549% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -27.145% |
| Bal Pharma Limited | 73.92 Million INR | -673.521% |
| Strides Pharma Science Limited | -706.14 Million INR | 180.976% |
| Venus Remedies Limited | 284.9 Million INR | -100.697% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 73.638% |
| Nectar Lifesciences Limited | 49.95 Million INR | -1044.749% |
| Shilpa Medicare Limited | 318.74 Million INR | -79.393% |
| Aarti Drugs Limited | 1.71 Billion INR | 66.643% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 57.465% |
| Suven Life Sciences Limited | -1.05 Billion INR | 154.418% |
| Ind-Swift Limited | 142.31 Million INR | -301.792% |
| Valiant Laboratories Limited | 3.19 Million INR | -17791.176% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 89.653% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 110.078% |
| Themis Medicare Limited | 435.23 Million INR | -31.377% |
| Hikal Limited | 696.02 Million INR | 17.847% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 96.548% |
| Sequent Scientific Limited | -358.69 Million INR | 259.414% |
| Novartis India Limited | 851.9 Million INR | 32.879% |
| Wockhardt Limited | -4.63 Billion INR | 112.35% |
| Jubilant Pharmova Limited | 771 Million INR | 25.836% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -7962.634% |
| Neuland Laboratories Limited | 3 Billion INR | 80.945% |
| Morepen Laboratories Limited | 961.59 Million INR | 40.536% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -291.608% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 730.314% |